BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14522733)

  • 1. Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.
    Scaglia F; Marini J; Rosenberger J; Henry J; Garlick P; Lee B; Reeds P
    Am J Clin Nutr; 2003 Oct; 78(4):749-55. PubMed ID: 14522733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
    Yudkoff M; Daikhin Y; Nissim I; Jawad A; Wilson J; Batshaw M
    J Clin Invest; 1996 Nov; 98(9):2167-73. PubMed ID: 8903337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Egawa H; Inui A; Fujisawa T; Komatsu H; Tsukahara H; Uemoto S; Inomata Y
    Mol Genet Metab; 2013 Jul; 109(3):251-4. PubMed ID: 23669167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
    Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
    Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of incorporation of [15N]ammonia into plasma amino acids and urea.
    Patterson BW; Carraro F; Klein S; Wolfe RR
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E508-15. PubMed ID: 7573428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of ammonia metabolism in a patient with ornithine transcarbamylase deficiency using an 15N tracer.
    Kodama H; Samukawa K; Okada S; Nose O; Maki I; Yamaguchi M; Yabuuchi H
    Clin Chim Acta; 1983 Aug; 132(3):267-75. PubMed ID: 6616881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).
    Laemmle A; Gallagher RC; Keogh A; Stricker T; Gautschi M; Nuoffer JM; Baumgartner MR; Häberle J
    PLoS One; 2016; 11(4):e0153358. PubMed ID: 27070778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency.
    Peng MZ; Li XZ; Mei HF; Sheng HY; Yin X; Jiang MY; Cai YN; Su L; Lin YT; Shao YX; Liu L
    Clin Biochem; 2020 Oct; 84():63-72. PubMed ID: 32569589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
    Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
    Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
    Lee B; Yu H; Jahoor F; O'Brien W; Beaudet AL; Reeds P
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8021-6. PubMed ID: 10869432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.
    Laemmle A; Poms M; Hsu B; Borsuk M; Rüfenacht V; Robinson J; Sadowski MC; Nuoffer JM; Häberle J; Willenbring H
    Hepatology; 2022 Sep; 76(3):646-659. PubMed ID: 34786702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Murayama K; Kubota M; Kurokawa K; Murakami T; Kanazawa M; Takatani T; Ogawa A; Ogawa E; Yamamoto S; Adachi M; Kobayashi K; Takayanagi M
    Eur J Pediatr; 2006 Sep; 165(9):618-24. PubMed ID: 16703326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
    Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B
    Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C
    J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
    Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect.
    Nagasaka H; Komatsu H; Ohura T; Sogo T; Inui A; Yorifuji T; Murayama K; Takayanagi M; Kikuta H; Kobayashi K
    J Pediatr; 2004 Aug; 145(2):259-62. PubMed ID: 15289781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
    Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
    J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
    Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
    PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.